AMPAVANCE Trademark

Serial Number: 50111336

AMPAVANCE is a trademark filed by Neurocrine Switzerland GmbH on September 16, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Neurocrine Switzerland GmbH (2 trademarks)

Hegenheimermattweg 167A
Allschwil 4123 , CH

Entity Type: 27

Legal Representation

Attorney of Record

Allison Strickland Ricketts

3,342 trademarks filed View all →

Correspondence Address

Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.

151 West 42nd St., 17th Fl.

New York, NY 10036

United States

Trademark Details

Filing Date

September 16, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of mood disorders; pharmaceutical preparations for the treatment of depressive disorders; pharmaceutical preparations for the treatment of anhedonia; pharmaceutical preparations for the treatment of major depressive disorder (MDD); pharmaceutical preparations for the adjunctive treatment of major depressive disorder; pharmaceutical preparations for the treatment of bipolar disorder, post-traumatic stress disorder (PTSD), and attention-deficit / hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of central nervous system disorders

Providing medical information; providing medical information relating to treatment of major depressive disorder; providing medical information relating to treatment of psychiatric, mood, neurological, and central nervous system disorders

Pharmaceutical research and development services; medical and scientific research in the field of major depressive disorder; medical and scientific research in the field of psychiatric, mood, neurological, and central nervous system disorders; providing medical and scientific information in the field of pharmaceutical research and development